BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26074073)

  • 1. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.
    Mao DD; Gujar AD; Mahlokozera T; Chen I; Pan Y; Luo J; Brost T; Thompson EA; Turski A; Leuthardt EC; Dunn GP; Chicoine MR; Rich KM; Dowling JL; Zipfel GJ; Dacey RG; Achilefu S; Tran DD; Yano H; Kim AH
    Cell Rep; 2015 Jun; 11(11):1809-21. PubMed ID: 26074073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDC20 maintains tumor initiating cells.
    Xie Q; Wu Q; Mack SC; Yang K; Kim L; Hubert CG; Flavahan WA; Chu C; Bao S; Rich JN
    Oncotarget; 2015 May; 6(15):13241-54. PubMed ID: 25938542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CDC20-APC/SOX2 signaling axis: An achilles' heel for glioblastoma.
    Gujar AD; Yano H; Kim AH
    Mol Cell Oncol; 2016 May; 3(3):e1075644. PubMed ID: 27314081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
    Shin HJ; Lee S; Jung HJ
    J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells.
    Mao DD; Cleary RT; Gujar A; Mahlokozera T; Kim AH
    PLoS One; 2022; 17(6):e0270251. PubMed ID: 35737702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ubiquitylation of components of mitotic checkpoint complex in their dissociation from anaphase-promoting complex/cyclosome.
    Sitry-Shevah D; Kaisari S; Teichner A; Miniowitz-Shemtov S; Hershko A
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1777-1782. PubMed ID: 29432156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
    Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
    Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
    Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
    Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/C
    De K; Grubb TM; Zalenski AA; Pfaff KE; Pal D; Majumder S; Summers MK; Venere M
    Mol Cancer Res; 2019 Jul; 17(7):1519-1530. PubMed ID: 31036696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC20 promotes bone formation via APC/C dependent ubiquitination and degradation of p65.
    Du Y; Zhang M; Liu X; Li Z; Hu M; Tian Y; Lv L; Zhang X; Liu Y; Zhang P; Zhou Y
    EMBO Rep; 2021 Sep; 22(9):e52576. PubMed ID: 34382737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.
    Guerrero PA; Tchaicha JH; Chen Z; Morales JE; McCarty N; Wang Q; Sulman EP; Fuller G; Lang FF; Rao G; McCarty JH
    Oncogene; 2017 Nov; 36(47):6568-6580. PubMed ID: 28783169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-anaphase-promoting complex/cyclosome.
    Nath S; Chowdhury A; Dey S; Roychoudhury A; Ganguly A; Bhattacharyya D; Roychoudhury S
    Mol Cell Biol; 2015 Jan; 35(2):356-69. PubMed ID: 25368385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.
    Schrock MS; Stromberg BR; Scarberry L; Summers MK
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):80-91. PubMed ID: 32165320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
    Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
    Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interphase APC/C-Cdc20 inhibition by cyclin A2-Cdk2 ensures efficient mitotic entry.
    Hein JB; Nilsson J
    Nat Commun; 2016 Mar; 7():10975. PubMed ID: 26960431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
    Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
    Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase.
    Amador V; Ge S; Santamaría PG; Guardavaccaro D; Pagano M
    Mol Cell; 2007 Aug; 27(3):462-73. PubMed ID: 17679094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells.
    Zhang Q; Huang H; Liu A; Li J; Liu C; Sun B; Chen L; Gao Y; Xu D; Su C
    EBioMedicine; 2019 Apr; 42():397-407. PubMed ID: 30904606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.